PMID: 6163497Mar 7, 1981Paper

Patient-controlled dose regimen of methadone for chronic cancer pain

British Medical Journal
J SäweE Anggård

Abstract

Fourteen patients with severe cancer pain participated in a trial of methadone given in a fixed dose (10 mg) but at intervals selected by the patients themselves during the loading phase. The aim was to achieve rapid pain relief while avoiding the risk of toxicity from accumulation of methadone. As expected, the dosage intervals increased gradually over the first few days of treatment, the daily dose decreasing from 30-80 mg on the first day to 10-40 mg at the end of the week. Plasma concentrations of methadone varied sevenfold after four to five days (0.24 to 1.75 mumol/1; 7.4 to 54.2 microgram/100 ml). Eleven patients reported complete or almost complete pain relief and elected to continue with methadone after the study. In no case was treatment withdrawn because of intoxication. From these findings a patient-controlled dosage regimen of oral methadone may be an effective and safe alternative to parenteral narcotic medication, adjusting both for individual variation in pain intensity and for pharmacokinetics.

References

Dec 1, 1978·The American Journal of Nursing·A S ValentineM Weintraub
Oct 1, 1979·Acta Anaesthesiologica Scandinavica·A TamsenM H Holmdahl
Feb 19, 1977·British Medical Journal·P Symonds
Feb 1, 1977·Clinical Pharmacology and Therapeutics·G D OlsenN Gerber
Nov 1, 1972·Clinical Pharmacology and Therapeutics·C E Inturrisi, K Verebely

❮ Previous
Next ❯

Citations

Jan 1, 1993·European Journal of Clinical Pharmacology·K WolffR Calvert
Sep 1, 1989·Der Schmerz·J Jage
Dec 18, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Y ShirE M Davidson
Mar 1, 2012·European Journal of Clinical Pharmacology·Kristin MoksnesOla Dale
Jul 1, 1997·Journal of Pain and Symptom Management·S MercadanteL Barresi
Jul 11, 1985·The New England Journal of Medicine·K M Foley
Jul 11, 2000·Current Opinion in Oncology·I ManciniJ J Body
Mar 1, 2000·The Western Journal of Medicine·I B Anderson, T E Kearney
Aug 24, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wendy H OldenmengerAgnes Jager
Feb 1, 1996·Journal of Clinical Anesthesia·K A Lehmann
Jun 21, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Douglas J Weschules, Kevin T Bain
Jul 3, 2009·International Journal of Clinical Practice·W Leppert
Jan 1, 1989·The American Journal of Hospice Care·A G Lipman
Jan 1, 1997·European Journal of Pain : EJP·S Mercadante
Jul 1, 1985·Alcoholism, Clinical and Experimental Research·D M NovickA M Gelb
Jan 1, 1982·Acta Anaesthesiologica Scandinavica. Supplementum·J HansenE Anggård
Dec 7, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Viktoria Kharlamb, Helen Kourlas
Oct 22, 2013·The Cochrane Database of Systematic Reviews·Columba Quigley
Feb 1, 1993·Pain·R FainsingerE Bruera
May 1, 1996·Cancer Control : Journal of the Moffitt Cancer Center·C Ripamonti, E Bruera
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S MercadanteL Calderone
Nov 1, 1988·Anaesthesia and Intensive Care·H OwenK Rowley
Nov 5, 2017·Journal of Pain and Symptom Management·Sebastiano Mercadante, Eduardo Bruera
Jan 7, 1985·The Medical Journal of Australia·G Coates
Feb 1, 1996·Hematology/oncology Clinics of North America·N I Cherny, K M Foley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Pharmacology
R BjörkmanJ Hedner
Acta Anaesthesiologica Scandinavica. Supplementum
L Paalzow
Acta Anaesthesiologica Scandinavica. Supplementum
L PaalzowP Stenberg
© 2021 Meta ULC. All rights reserved